75 related articles for article (PubMed ID: 21693154)
21. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
22. Monoamine transporter as a target molecule for psychostimulants.
Sora I; Li B; Fumushima S; Fukui A; Arime Y; Kasahara Y; Tomita H; Ikeda K
Int Rev Neurobiol; 2009; 85():29-33. PubMed ID: 19607959
[TBL] [Abstract][Full Text] [Related]
23. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
Mortensen OV; Amara SG
J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
[TBL] [Abstract][Full Text] [Related]
24. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Yamashita M; Fukushima S; Shen HW; Hall FS; Uhl GR; Numachi Y; Kobayashi H; Sora I
Neuropsychopharmacology; 2006 Oct; 31(10):2132-9. PubMed ID: 16407898
[TBL] [Abstract][Full Text] [Related]
25. [Function of monoamine neurotransmitter transporters].
Sasa M
Nihon Rinsho; 2001 Aug; 59(8):1457-64. PubMed ID: 11519142
[TBL] [Abstract][Full Text] [Related]
26. Transient developmental expression of monoamine transporters in the rodent forebrain.
Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
[TBL] [Abstract][Full Text] [Related]
27. A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.
Hall FS; Schwarzbaum JM; Perona MT; Templin JS; Caron MG; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2011 Feb; 175():315-27. PubMed ID: 21129446
[TBL] [Abstract][Full Text] [Related]
28. Expression and immunolocalization of the plasma membrane monoamine transporter in the brain.
Dahlin A; Xia L; Kong W; Hevner R; Wang J
Neuroscience; 2007 May; 146(3):1193-211. PubMed ID: 17408864
[TBL] [Abstract][Full Text] [Related]
29. Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.
Jones JD; Hall FS; Uhl GR; Riley AL
Pharmacol Biochem Behav; 2010 Feb; 94(4):580-7. PubMed ID: 19969013
[TBL] [Abstract][Full Text] [Related]
30. Altered neurocircuitry in the dopamine transporter knockout mouse brain.
Zhang X; Bearer EL; Boulat B; Hall FS; Uhl GR; Jacobs RE
PLoS One; 2010 Jul; 5(7):e11506. PubMed ID: 20634895
[TBL] [Abstract][Full Text] [Related]
31. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
Numachi Y; Ohara A; Yamashita M; Fukushima S; Kobayashi H; Hata H; Watanabe H; Hall FS; Lesch KP; Murphy DL; Uhl GR; Sora I
Eur J Pharmacol; 2007 Oct; 572(2-3):120-8. PubMed ID: 17673199
[TBL] [Abstract][Full Text] [Related]
32. Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.
Fentress HM; Klar R; Krueger JJ; Sabb T; Redmon SN; Wallace NM; Shirey-Rice JK; Hahn MK
Genes Brain Behav; 2013 Nov; 12(8):749-59. PubMed ID: 24102798
[TBL] [Abstract][Full Text] [Related]
33. Expression and functional activity of neurotransmitter system components in sea urchins' early development.
Nikishin DA; Milošević I; Gojković M; Rakić L; Bezuglov VV; Shmukler YB
Zygote; 2016 Apr; 24(2):206-18. PubMed ID: 25920999
[TBL] [Abstract][Full Text] [Related]
34. Monoamine transporters: from genes to behavior.
Gainetdinov RR; Caron MG
Annu Rev Pharmacol Toxicol; 2003; 43():261-84. PubMed ID: 12359863
[TBL] [Abstract][Full Text] [Related]
35. Human genetics and pharmacology of neurotransmitter transporters.
Lin Z; Madras BK
Handb Exp Pharmacol; 2006; (175):327-71. PubMed ID: 16722243
[TBL] [Abstract][Full Text] [Related]
36. Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters.
Ghose S; Fujita M; Morrison P; Uhl G; Murphy DL; Mozley PD; Schou M; Halldin C; Innis R
Synapse; 2005 May; 56(2):100-4. PubMed ID: 15729740
[TBL] [Abstract][Full Text] [Related]
37. Agonistic and antagonistic bivalent ligands for serotonin and dopamine receptors including their transporters.
Decker M; Lehmann J
Curr Top Med Chem; 2007; 7(4):347-53. PubMed ID: 17305576
[TBL] [Abstract][Full Text] [Related]
38. Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6.
Sogawa C; Mitsuhata C; Kumagai-Morioka K; Sogawa N; Ohyama K; Morita K; Kozai K; Dohi T; Kitayama S
PLoS One; 2010 Aug; 5(8):e11945. PubMed ID: 20700532
[TBL] [Abstract][Full Text] [Related]
39. Expression and distribution of dopamine transporter in cardiac tissues of the guinea pig.
Palomar AR; Larios BN; De Sánchez VC; Pérez LM; López Fde L; Flores G; Gómez-Villalobos Mde J
Neurochem Res; 2011 Mar; 36(3):399-405. PubMed ID: 21170736
[TBL] [Abstract][Full Text] [Related]
40. Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disorders.
Hoyer D; Thakker DR; Natt F; Maier R; Huesken D; Müller M; Flor P; VAN DER Putten H; Schmutz M; Bilbe G; Cryan JF
J Recept Signal Transduct Res; 2006; 26(5-6):527-47. PubMed ID: 17118797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
